# Imaging Evaluation of Central Nervous Autoimmune Diseases

> **NCT04822623** · — · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 300 (estimated)

## Conditions studied

- MS (Multiple Sclerosis)
- NMO Spectrum Disorder

## Interventions

- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT04822623
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-07-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04822623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04822623, "Imaging Evaluation of Central Nervous Autoimmune Diseases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04822623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*